FDA backs Pfizer COVID-19 boosters for seniors, high-riskFDA backs Pfizer COVID-19 boosters for seniors, high-riskFDA backs Pfizer COVID-19 boosters for seniors, high-risk

FDA backs Pfizer COVID-19 boosters for seniors, high-risk

The uncertainties were yet another reminder that the science surrounding boosters is more complicated than the Biden administration suggested when the president and his top aides rolled out their plan at the White House last month.

from Section Page News - Modern Healthcare https://ift.tt/39xbB3S

US panel backs COVID-19 boosters only for elderly, high-riskUS panel backs COVID-19 boosters only for elderly, high-riskUS panel backs COVID-19 boosters only for elderly, high-risk

US panel backs COVID-19 boosters only for elderly, high-risk

The twin votes represented a heavy blow to the Biden administration's sweeping effort to shore up nearly all Americans' protection amid the spread of the highly contagious delta variant.

from Section Page News - Modern Healthcare https://ift.tt/3ltDjnu